Botulinum toxin type A vs placebo
Adverse events (reported at any time) (2 RCT, 169 participants) · adults with blepharospasm
Botulinum toxin type A showed no clear difference in adverse events (reported at any time) (2 RCT, 169 participants) compared with placebo (low certainty).
1 finding from 1 review
- RR 1.18 [0.87, 1.6]Studies not reportedLow